Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nedaplatin or Cisplatin Combined With Pemetrexed in the First Line Treatment of Advanced Adenocarcinoma：A Prospective Multi-center Phase III Randomized Controlled Trial

NCT02607592 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02607592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02607592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nedaplatin or Cisplatin Combined With Pemetrexed in the First Line Treatment of Advanced Adenocarcinoma：A Prospective Multi-center Phase III Randomized Controlled Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2015
Completion date
December 31, 2022
Enrollment
293 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma，non-small-cell lung